Research & Pharma Services

Innovative assays that can help answer your most challenging genomic questions, comprehensively

Genomic Testing Cooperative (GTC) offers a broad range of DNA and RNA sequencing services, AI-driven software’s, analysis tools and support services for research projects and clinical trials. Our assays can be tailored to meet your clinical trial requirements and expanded upon as needed.

Therapeutic areas we have expertise: 

Solid
Tumor

Hematologic
Malignancies

Liquid
Biopsy

Molecular and
Traditional IHC Assays

AI
Algorithms

Customized
Assays

How we can help you

GTC Research

Learn more 

Please fill up the following form and a member of our staff shall contact you for more details, answering any questions you may have.

The Co-Op Network

  • GTC has numerous co-op members who can be used as testing sites or trial enrollment sites.  
  • Assays can be transferred to any lab in the world to help support trial needs in any country.
  • Leverage the power of multiple institutions for broader perspectives on testing, therapeutic implementation, data and more… 

Why GTC:

  • Unique menu offering numerous innovative NGS applications 
  • Rapid turn-around time 
  • Project scalability 
  • Robust AI and deep learning platform to help with report interpretation 
  • World class expertise in both hematologic cancers, solid tumors and immuno-oncology 
  • Access to over 40k data records 

GTC’s Assays

Liquid Trace™ (cfDNA and cfRNA)

  • Pan tumor assay for both solid tumors and hematologic malignancies
  • Full gene sequences of 284 DNA genes and more than 1600 RNA genes
  • Reliable fusion detection of both known and novel genes
  • Covers numerous biomarkers like HRR, PD-L1, HER2 and more
  • Includes viral DNA testing for HPV and EBV

Liquid Trace™:

Solid Tumor Profile
284 / >1600 Genes
  • Indications


    Chromosomal abnormalities, gene amplifications, HRR, MRD, ALK, ROS1, RET, NTRK1/2/3, BRAF, CIC, EWSR1, PD-L1, MET exon 14 skipping and various alternative splicing, MET, HER2, PIK3CA, PTEN, EGFR amplification, AKT1, RAS
  • Sample Type

    Peripheral blood
  • Results Reported

    DNA+RNA
  • Monitoring
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Liquid Trace™:

Hematology Profile
284 / >1600 Genes
  • Indications


    Chromosomal abnormalities, gene amplifications, multiple myeloma, lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, MDS, CMML, AML, MPN, lymphoma, MRD, VEXAS syndrome, HPV, EBV
  • Sample Type

    Peripheral blood
  • Results Reported

    DNA+RNA
  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Solid Tumor Profile Plus

  • Pan tumor assay focused on solid tumors
  • 434 DNA genes and more than 1600 RNA genes
  • Covers major biomarkers like MSI, TMB, HRD and more
  • Detect chromosomal structural changes
  • Reliable fusion detection,
  • Alternative splicing,
  • Gene expression
  • Exon skipping
  • Immune profiling

Solid Tumor

Profile Plus™
434 / >1600 Genes
  • Indications

    ALK, ROS1, RET, NTRK1/2/3, BRAF, CIC, EWSR1, PD-L1, MET exon 14 skipping and various alternative splicing, MET, HER2, EGFR amplification, PIK3CA, PTEN, AKT1, RAS and HRD
  • Sample Type

    FFPE

    -
  • Results Reported

    DNA+RNA
  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Hematology Profile Plus

  • Pan tumor assay focused on hematologic malignancies
  • 179 DNA genes and more than 1600 RNA genes
  • Classify all subtypes of leukemia, lymphomas, myelomas, MDS, VEXAS, CHIP and more
    • AML
    • CMML
  • Detect chromosomal structural changes and chromosomal rearrangements
  • Gene expression

Hematology

Profile Plus™
284 / >1600 Genes
  • Indications

    Classification and diagnosis of lymphoma, multiple myeloma, acute lymphoblastic leukemia, acute myeloid leukemia Includes IgVH mutation status
  • Sample Type

    Bone marrow,
    Peripheral blood,
    Fresh tissue
  • Results Reported

    DNA+RNA
  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Immunohistochemistry (IHC)

GTC has added Immunohistochemistry (IHC) testing to complement our next-gen sequencing capabilities. We can bring up an antibody or assay to use in your research project. Our NGS can also do a comparison of the IHC and NGS findings. 
Capabilities include: 

  • Histology 
  • Custom IHC 
  • Image analysis  

AI Algorithms

GTC offers several world class AI software’s available for your research and clinical trial projects with multiple publications in top journals. Our AI tools can assist with:

  • Picking the correct cut offs for biomarkers
  • Identify responders from non-responders
  • Other critical testing algorithms

Our AI software’s can be customized and tuned to work with any assay

Customized Assays

Genomic Testing Cooperative (GTC) offers all types sequencing services for research projects and clinical trials. We provide a wide range of capabilities from Sanger sequencing to next generation sequencing. All projects are performed in our CAP and CLIA accredited laboratory by Clinical Laboratory Specialists (CLS).

We can provide several standard tumor profiling panels or we can collaborate on custom panel development for projects in the field of oncology and immuno-oncology. All studies have optional bioinformatics support and access to our deep learning tools or GTC can deliver raw data files for interpretation with your own tools.

Types of Pharma and Research Support Services We Offer:

  • Next-gen sequencing
  • Sanger sequencing
  • RNA-analysis
  • Solid tumor research
  • Hematology research
  • Liquid biopsy
  • Custom assay development
  • AI analysis
  • Bioinformatics support
  • CDx development
  • Biomarker discovery

GTC has a collaboration agreement in place with laboratories to perform IHC and flow cytometry and can perform additional services and capabilities beyond sequencing if your project requires it.

Contact Us to learn more about our model of cooperation